The study, published in the journal Advanced Science, centers on a class of compounds known as luminescent organic radicals. Unlike most fluorescent molecules, which contain paired electrons in their ground state, radicals carry unpaired electrons. That unpaired electron gives them two remarkable properties at once. It allows them to emit light through a mechanism that differs from conventional fluorescence, and it makes them paramagnetic, meaning they can accelerate the relaxation of nearby hydrogen nuclei, the very property that MRI contrast agents exploit to brighten images. In principle, a single radical molecule could therefore serve both imaging modalities, something that conventional fluorescent dyes and gadolinium-based contrast agents cannot do on their own.

The challenge, as Associate Professor Ken Albrecht of Kyushu University’s Institute for Materials Chemistry and Engineering, who led the study, explains, is that the two technologies operate on fundamentally different principles. In fluorescence imaging, a molecule absorbs photons at one wavelength and re-emits them at another, and the detector captures that emitted light. MRI, meanwhile, works by detecting the nuclear spin of hydrogen atoms in the water molecules that make up most of the body’s soft tissue. A contrast agent improves the clarity of the resulting image by altering how quickly those spins relax back to equilibrium after being excited by the scanner’s radiofrequency pulses. Designing one molecule that satisfies both sets of requirements, and does so safely in a watery biological environment, has proven extraordinarily difficult.

The Kyushu-led team began with a luminescent organic radical called tris(2,4,6-trichlorophenyl) methyl, abbreviated TTM. This trityl-type radical had already shown promise in earlier work, producing fluorescence and exhibiting the paramagnetic behavior needed for MRI contrast. But there was a critical obstacle: TTM and its early derivatives were hydrophobic, meaning they repel water. In the aqueous environment of blood, cells, and interstitial fluid, hydrophobic molecules tend to clump together, lose their optical properties, and become difficult or impossible to deliver safely. For any radical-based probe to be useful in biological systems, water solubility was non-negotiable.

The path to solubility was not straightforward. The researchers’ first generation of modified molecules achieved good MRI activity but suffered from extremely weak fluorescence, a disappointing trade-off that threatened to undo the whole point of a dual-modal probe. Through iterative chemical optimization, the team systematically adjusted the molecular architecture, tuning the balance between the radical core that governs spin behavior and the substituents that govern light emission and solubility. The result of this refinement campaign was a pair of new compounds, designated TTM-trisTP3B and TTM-trisTP9B, in which the central radical is bound in three directions to water-soluble groups, shielding the hydrophobic core while preserving its electronic properties.

Both new molecules produced deep-red fluorescence in water, a region of the spectrum that is particularly valuable for biological imaging because longer wavelengths scatter less in tissue and are less likely to be masked by the autofluorescence that biological molecules naturally emit. Deep-red and near-infrared light therefore offers a better balance of penetration depth and signal clarity than the blue and green light emitted by many conventional dyes. The fact that these radicals achieve such emission while remaining fully water-soluble marks a meaningful advance over earlier hydrophobic generations of the TTM scaffold.

The performance of the new compounds in MRI tests was equally striking. When the researchers evaluated them in phantom images, the standard laboratory test beds used to characterize contrast agents before any biological application, both molecules enhanced image contrast approximately 2.5 to 4.5 times more strongly than previously reported water-soluble TTM radicals. That improvement matters because contrast enhancement is the measure by which MRI agents are judged: a stronger effect means a lower dose can be used, reducing both cost and any potential biological burden. It also suggests that the chemical modifications did not compromise the unpaired electron’s ability to interact with nearby water protons, the essential mechanism of radical-based MRI contrast.

To probe biological compatibility, the team tested TTM-trisTP3B in living cells. The molecule was confirmed to emit fluorescence around the cell nucleus, indicating that it enters cells and distributes within them rather than being excluded or immediately degraded. Encouragingly, the fluorescence persisted for at least 24 hours, a stability that would allow long-term tracking of cells in experiments. Sustained signal is a practical prerequisite for many applications, from following transplanted stem cells to monitoring the migration of immune cells, and many fluorescent probes fade far more quickly under the continuous illumination and metabolic stress of live-cell imaging.

Perhaps the most consequential aspect of the work is what the new probes do not contain. Conventional MRI contrast agents rely on paramagnetic metals, most commonly gadolinium, a heavy lanthanide element that is highly toxic in its free form and must be tightly chelated to be safe. Concerns about gadolinium retention in the brain and other tissues, along with rare but serious reactions in patients with kidney impairment, have driven a sustained search for alternatives. A metal-free contrast agent built entirely from organic elements sidesteps those concerns at the molecular level, offering the prospect of safer, less toxic imaging agents. Because the same molecule also fluoresces, a single injection could in principle serve both a whole-body MRI scan and a high-resolution fluorescence examination, a genuinely dual-modal capability.

The researchers caution that the full utility of these molecules remains to be established. Animal studies will be needed to assess how the compounds behave in a living organism, including their circulation time, biodistribution, clearance, and long-term toxicity, before any clinical relevance can be claimed. Nevertheless, the present results establish an important proof of concept for metal-free fluorescence and MRI dual-modal imaging, and they introduce a unifying strategy that could reshape how multimodal probes are designed. The implications may extend beyond medicine. Luminescent organic radicals have attracted growing attention in quantum information science, quantum sensing, and advanced electronic materials, fields where the same unpaired electrons that make these molecules useful contrast agents also make them sensitive probes of their environment. The Kyushu team suggests that their results may serve as a foundation for future quantum sensing technologies, meaning that a molecule born from the practical demands of medical imaging could ultimately find a second life at the frontier of quantum technology, where the ability to control and read out single electron spins is the currency of progress.

Subject of Research: Development of a water-soluble, metal-free luminescent organic radical for dual-modal fluorescence and MRI imaging

Article Title: A new metal-free and water-soluble molecule that can produce florescence and used as MRI contrast material

Article References: A new metal-free and water-soluble molecule that can produce florescence and used as MRI contrast material. (n.d.). Original publication

Image Credits: AI Generated

DOI: Not provided

Keywords: Kyushu University, organic radicals, TTM, fluorescence imaging, MRI contrast agent, water-soluble molecule, dual-modal imaging, metal-free probe, bioimaging, gadolinium alternatives, Advanced Science, trityl radical